摘要 |
<p>Disclosed are compounds of the formula Chemical formula (I) or a pharmaceutically acceptable salt thereof, wherein M<sup>2</sup> is N; X is a bond, optionally substituted alkylene, alkenylene, -O-, -CH2N(R<sup>12</sup>)-, -N(R<sup>12</sup>)CH2-, -N(R<sup>12</sup>)-, -NHC(O)-, -OCH2-, -CH2O-, or -S(O)0-2-; and Y is -(CH2)1-2-, -C(=O)-, -C(=NOR<sup>13</sup>)- or -SO0-2-; or M<sup>1</sup> is N; M<sup>2</sup> is N or CH; X is a bond, alkylene, alkenylene, -C(O)-, -NHC(O)-, -OC(O)- or -S(O)1-2-; Y is -(CH2)1-2-, -C(=O)- or -SO0-2-; and when M<sup>2</sup> is CH, Y is also Y is -O- or -C(=NOR<sup>13</sup>)-; Z is a bond or optionally substituted alkylene or alkenylene; U and W are CH, or one is CH and one is N; R<sup>1</sup> is optionally substituted alkyl, cycloalkyl, aryl, arylalkyl, heteroaryl, heterocycloalkyl; R<sup>2</sup> is optionally substituted alkyl, alkenyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl or heterocycloalkyl; and the remaining variables are as defined in the specification; and compositions and methods of treating obesity, metabolic syndrome and a cognition deficit disorder, alone or in combination with other agents.</p> |
申请人 |
SCHERING CORPORATION. |
发明人 |
ASLANIAN, ROBERT G.;BERLIN, MICHAEL Y.;MCCORMICK, KEVIN D.;MUTAHI, MWANGI W.;TOM, WING C.;DE LERA RUIZ, MANUEL;SOLOMON, DANIEL M. |